University of Patras
In vitro έλεγχος παραγωγής biofilm από στελέχη Staphylococcus (πρότυπα και κλινικά) παρουσία αντιμικροβιακών παραγόντων: αντιβιοτικού και βακτηριοφάγων ελεύθερων και εγκλωβισμένων σε λιποσώματα
Abstract
dc:descriptionDespite all the precautions taken in hospitals to prevent infections, medical implants are susceptible to infection and contamination, even though this modern medical technology is playing an increasingly important role in the healthcare system. Microorganisms that cause device-associated infections are part of the normal patient microbiota and have the ability to form biofilms. The most common bacterial pathogens are staphylococci, specifically Staphylococcus and Staphylococcus aureus. The purpose of this thesis was to investigate anti-staphylococcal activity of daptomycin and bacteriophage K, alone or in combination, against biofilm-producers and non-producers S. aureus and S. epidermidis strains, under biofilm forming and cells’ proliferation conditions. Daptomycin and bacteriophage K (ATCC 19685B1), in different concentrations, were tested against 10 Staphylococcus aureus and 10 S. epidermidis, characterized by phenotypes and genotypes. The quantitative microtiter plate (crystal violet, CV), methylthiazoltetrazolium (MTT), and growth curve (GC) assays were performed. No statistically significant difference was found between species, whereas daptomycin alone performed better using medium and high concentrations of the drug and bacteriophage K was more active against strains with higher susceptibility, by CV and MTT assays. Best results were achieved using both agents combined in high concentrations. Bacteriophage K was effective within 3.8 and 2.4 h, depending on the concentration used, by the GC assay. Combination of daptomycin with bacteriophage K was more effective against staphylococci, depending on the concentrations used and strains’ susceptibility. Further studies are needed to evaluate if this approach might be a choice for prevention or therapy of biofilm-associated infections. The purpose of the follow up study was to investigate the anti-staphylococcal activity of liposomal daptomycin against four biofilm-producing S. aureus and S. epidermidis clinical strains, three of which are methicillin-resistant. Neutral and negatively charged daptomycin-loaded liposomes were prepared using two methods, namely, thin-film hydration (TFH), and dehydration–rehydration vesicle (DRV) method; moreover, they were characterized for drug encapsulation (EE%), size distribution, zeta-potential, vesicle stability, drug release, and drug integrity. Liposomal encapsulation protected daptomycin from degradation and preserved its bioactivity. Biofilm mass (crystal violet, CV), biofilm viability (MTT), and growth curve (GC) assays evaluated the antimicrobial activity of neutral and negatively charged daptomycin-liposomes towards planktonic bacteria and biofilms. Neutral liposomes exhibited dramatically enhanced inhibition of bacterial growth (compared to the free drug) for all species studied, while negatively charged liposomes were totally inactive. Biofilm prevention and treatment studies revealed high antibiofilm activity of liposomal daptomycin. Neutral liposomes were more active for prevention and negative charge ones for treating established biofilms. Planktonic bacteria as well as the matured biofilms of low daptomycin-susceptible, methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus epidermidis (MRSE) strains were almost completely eradicated by liposomal-daptomycin, indicating the need for their further exploration as antimicrobial therapeutics. Preliminary studies with liposomal Bacteriophage K were also carried out. The results of the preliminary studies demonstrated increased antimicrobial activity of liposomal phage compared to the free phage, indicating that the approach is highly interesting, and should be further exploited.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Plota, Maria
- Πλώτα, Μαρία
Subjects
dc:subject × 22- Σταφυλόκοκκοι
- Βιομεμβράνη
- Δαπτομυκίνη
- Βακτηριοφάγοι
- Λιποσώματα
- Staphylococcus
- Biofilm
- Daptomycin
- Bacteriophage
- Liposome
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Μικροβιολογία (ιατρική)
- Άλλες Ιατρικές Επιστήμες
- Ιατρική έρευνα και Πειραματική ιατρική
- Ιατρική, άλλοι τομείς
- Clinical Medicine
- Medical and Health Sciences
- Microbiology (medical)
- Other Medical Sciences
- Research and Experimental medicine
- Medicine, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/63080